East China Pharmaceuticals and others have established an equity investment partnership in Hangzhou with a total investment of 2 billion.

Tianyancha's business information shows that recently, Hangzhou Fuguang Hongze Equity Investment Partnership Enterprise was established, with Niu Feng as the executive managing partner. The amount of investment is 2 billion RMB, and the business scope includes equity investment and venture capital. The partner information shows that the partnership enterprise was jointly funded by Shanghai Fuguang Private Equity Fund Management Co., Ltd., East China Pharmaceutical, Hangzhou Industrial Investment Co., Ltd., and Hangzhou Gongshu Industrial Fund Co., Ltd.